Linifanib (ABT-869) Potentiates the Efficacy of Chemotherapeutic Agents through the Suppression of Receptor Tyrosine Kinase-Mediated AKT/mTOR Signaling Pathways in Gastric Cancer.

Jing Chen,Jiawei Guo,Zhi Chen,Jieqiong Wang,Mingyao Liu,Xiufeng Pang

Linifanib (ABT-869) Potentiates the Efficacy of Chemotherapeutic Agents through the Suppression of Receptor Tyrosine Kinase-Mediated AKT/mTOR Signaling Pathways in Gastric Cancer.

2016

Jing Chen
Jiawei Guo
Zhi Chen
Jieqiong Wang
Mingyao Liu
Xiufeng Pang

Linifanib (ABT-869) Potentiates the Efficacy of Chemotherapeutic Agents through the Suppression of Receptor Tyrosine Kinase-Mediated AKT/mTOR Signaling Pathways in Gastric Cancer

Keywords:

PI3K/AKT/mTOR pathway
Tyrosine
Protein kinase B
Receptor Protein-Tyrosine Kinases
Receptor tyrosine kinase
Cancer
Linifanib
Pharmacology
Signal transduction
Medicine
Epidermal growth factor receptor
Growth factor receptor
Vascular endothelial growth factor
Angiogenesis

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations